US Stock MarketDetailed Quotes

MNPR Monopar Therapeutics

Watchlist

22.5300
+1.8300+8.84%

Close Nov 29 13:00 ET

22.2500
-0.2800-1.24%

Post 17:01 ET

118.91MMarket Cap-11378P/E (TTM)

Monopar Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Monopar Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
--	2024/Q3	0.000 / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

--2024/Q30.000 / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Monopar Therapeutics Earnings Reports

Monopar Therapeutics | 8-K: Monopar Therapeutics Reports Third Quarter 2024 Financial Results and Recent Developments

Nov 8 08:05 ET

Monopar Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 8 08:05 ET

Monopar Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 9 08:07 ET

Monopar Therapeutics | 8-K: Monopar Therapeutics Reports Second Quarter 2024 Financial Results and Recent Developments

Aug 9 08:02 ET

Analyst Rating

Updated: Nov 30, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall